Interest in Taking HIV Pre-exposure Prophylaxis Is Associated with Behavioral Risk Indicators and Self-Perceived HIV Risk Among Men Who Have Sex with Men Attending HIV Testing Venues in Sweden.


Journal

Archives of sexual behavior
ISSN: 1573-2800
Titre abrégé: Arch Sex Behav
Pays: United States
ID NLM: 1273516

Informations de publication

Date de publication:
08 2020
Historique:
received: 04 12 2019
accepted: 05 05 2020
revised: 01 04 2020
pubmed: 5 6 2020
medline: 11 11 2020
entrez: 5 6 2020
Statut: ppublish

Résumé

This study explored factors associated with interest in taking PrEP among men who have sex with men (MSM) attending HIV testing venues in Sweden. Data from 658 HIV-negative respondents, surveyed by a questionnaire at six sites, were analyzed descriptively and by univariable and multivariable logistic regression. A total of 453 (68.8%) of the respondents expressed interest in taking PrEP. Reporting self-perceived risk of HIV acquisition as moderate or high, reporting ≥ 5 partners for condomless anal intercourse during the past year, and reporting hard drug use during the past year were independently associated with interest in taking PrEP. However, an aggregated variable of self-reported rectal gonorrhea, rectal chlamydia, or syphilis infection during the past year was not associated with interest in taking PrEP. Overall, Swedish MSM were well-informed regarding PrEP, and interest in taking PrEP was positively associated with sexual risk indicators.

Identifiants

pubmed: 32495243
doi: 10.1007/s10508-020-01740-9
pii: 10.1007/s10508-020-01740-9
pmc: PMC7316853
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2165-2177

Références

PLoS One. 2018 Sep 13;13(9):e0204067
pubmed: 30212547
Sex Transm Infect. 2017 Sep;93(6):438-444
pubmed: 28108701
AIDS Behav. 2017 May;21(5):1278-1287
pubmed: 27531461
Lancet. 2016 Jan 2;387(10013):53-60
pubmed: 26364263
Sex Transm Infect. 2019 Dec;95(8):575-579
pubmed: 31113905
AIDS Care. 2011 Dec;23(12):1644-51
pubmed: 22117126
Sex Transm Dis. 2018 May;45(5):325-331
pubmed: 29465683
JAMA. 2019 Apr 9;321(14):1380-1390
pubmed: 30964528
Sex Transm Infect. 2020 Mar;96(2):124-130
pubmed: 31171592
Sex Transm Infect. 2018 Nov;94(7):494-501
pubmed: 29700052
BMC Public Health. 2017 Jan 31;17(1):139
pubmed: 28143465
AIDS Behav. 2016 Jul;20(7):1435-42
pubmed: 26966013
Int J STD AIDS. 2018 Mar;29(4):350-356
pubmed: 28835196
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
Lancet HIV. 2017 Sep;4(9):e402-e410
pubmed: 28747274
Sex Transm Infect. 2016 Jun;92(4):279-85
pubmed: 26801225
PLoS One. 2018 Oct 19;13(10):e0204738
pubmed: 30339690
Cult Health Sex. 2016;18(6):639-53
pubmed: 26569463
Sex Transm Infect. 2019 Aug;95(5):342-350
pubmed: 30979782
Subst Use Misuse. 2016 Jul 28;51(9):1093-103
pubmed: 27158751
AIDS Behav. 2018 Apr;22(4):1096-1099
pubmed: 29243109
Soc Sci Med. 2017 Jan;172:115-123
pubmed: 27866750
AIDS Patient Care STDS. 2013 Apr;27(4):248-54
pubmed: 23565928
Int J STD AIDS. 2018 Apr;29(5):435-442
pubmed: 28927341
J Assoc Nurses AIDS Care. 2019 May-Jun;30(3):301-311
pubmed: 31008817
J Sex Transm Dis. 2013;2013:953123
pubmed: 26316968
Int J Drug Policy. 2017 Nov;49:24-25
pubmed: 28873358
AIDS. 2015 May 15;29(8):955-64
pubmed: 25915169
J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):421-7
pubmed: 22487585
J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):250-258
pubmed: 28708811
Curr Infect Dis Rep. 2019 Jun 21;21(8):28
pubmed: 31227999
JMIR Public Health Surveill. 2018 Jan 23;4(1):e13
pubmed: 29362213
Sex Transm Infect. 2015 Dec;91(8):564-8
pubmed: 26163510
Sex Transm Infect. 2019 Sep;95(6):449-454
pubmed: 30918121
J Clin Nurs. 2016 Dec;25(23-24):3605-3618
pubmed: 27135281
BMJ Open. 2017 Oct 16;7(10):e015142
pubmed: 29042372
N Engl J Med. 2015 Dec 3;373(23):2237-46
pubmed: 26624850
Sex Health. 2018 Apr;15(2):151-156
pubmed: 29580377
Int J Drug Policy. 2018 May;55:231-241
pubmed: 29402683
Sex Transm Infect. 2013 May;89(3):207-11
pubmed: 23015689
AIDS. 2016 Jul 31;30(12):1973-83
pubmed: 27149090

Auteurs

Tobias Herder (T)

Division of Social Medicine and Global Health, Department of Clinical Sciences, Malmö, Lund University, Jan Waldenströms gata 35, 214 28, Malmö, Sweden. tobias.herder@med.lu.se.

Anette Agardh (A)

Division of Social Medicine and Global Health, Department of Clinical Sciences, Malmö, Lund University, Jan Waldenströms gata 35, 214 28, Malmö, Sweden.

Per Björkman (P)

Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.

Fredrik Månsson (F)

Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH